Tissue Plasminogen Activator Levels after Single Intracisternal Injection in Patients with Subarachnoid Hemorrhage

Neurologia Medico-Chirurgica

Volumn 44, Issue 2, 2004, Pages 55-60

  Jito, Junya ^a   Nakasu, Yoko ^b   Nakasu, Satoshi ^a   Hatsuda, Naoki ^a   Matsuda, Masayuki ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Aneurysm; Cerebrospinal fluid; Fibrinolytic therapy; Subarachnoid hemorrhage; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; RINGER SOLUTION;

ADULT; AGED; ANEURYSM SURGERY; ARTICLE; BLOOD CLOT LYSIS; BOLUS INJECTION; BRAIN ARTERY ANEURYSM RUPTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CEREBROSPINAL FLUID LEVEL; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; LAVAGE; LINEAR REGRESSION ANALYSIS; LUMBAR PUNCTURE; MALE; PH; POSTOPERATIVE CARE; PREOPERATIVE CARE; SUBARACHNOID HEMORRHAGE; SURGICAL DRAINAGE; SURGICAL INFECTION;

ADULT; AGED; AGED, 80 AND OVER; CISTERNA MAGNA; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATORS; SUBARACHNOID HEMORRHAGE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 1542349232     PISSN: 04708105     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.44.55     Document Type: Article

References (17)

1. Azmi-Ghadini H, Heary RF, Farkas JE, Hunt CD: Use of intraventricular tissue plasminogen activator and Guglielmi detachable coiling for acute treatment of casted ventricles from cerebral aneurysm hemorrhage: two technical case reports. Neurosurgery 50: 421-425, 2002
2. Ezura M, Takahashi A, Ogasawara K, Yoshimoto T: Intra-aneurysmal GDC embolization followed by intrathecal tPA administration for poor-grade basilar tip aneurysm. Surg Neurol 47: 144-147, 1997
3. Findlay JM, Kassell NF, Weir BKA, Haley EC Jr, Kongable G, Germanson T, Truskowski L, Alves WM, Holness RO, Knuckey NW, Yonas H, Steinberg GK, West M, Winn HR, Ferguson G: A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37: 168-178, 1995
4. Fisher CM, Kistler IP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1-9, 1980
5. Gorski R, Zabek M, Jarmuzek P: Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms. Neurol Neurochir Pol 34 (6 Suppl): 41-47, 2000
6. Hamada J, Mizuno T, Kai Y, Morioka M, Ushio Y: Microcatheter intrathecal urokinase infusion into cisterna magna for prevention of cerebral vasospasm: preliminary report. Stroke 31: 2141-2148, 2000
7. Ikeda K, Asakura H, Futami K, Yamashita J: Coagulative and fibrinolytic activation in cerebrospinal fluid and plasma after subarachnoid hemorrhage. Neurosurgery 41: 344-350, 1997
8. Kajimoto Y, Ohta T, Kuroiwa T: Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs. Neurosurgery 40: 572-577, 1997
9. Kawada S, Kinugasa K, Meguro T, Hirotsune N, Tokunaga K, Kamata I, Nakashima H, Ohmoto T: Experimental study of intracisternal administration of tissue-type plasminogen activator followed by cerebrospinal fluid drainage in the ultra-early stage of subarachnoid haemorrhage. Acta Neurochir (Wien) 141: 1331-1338, 2000
10. Kim YH, Park JH, Hong SH, Koh JY: Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 284: 647-650, 1999
11. Marder VJ, Sherry S: Thrombolytic therapy: current status. N Engl J Med 318: 1512-1520, 1988
12. Mayfrank L, Rohde V, Gilsbach JM: Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations. Br J Neurosurg 13: 128-131, 1999
13. Nakasu Y, Handa J: [The efficacy of an intraoperative one-shot t-PA and irrigation for treating aneurysmal subarachnoid hemorrhage]. No Shinkei Geka Journal 5: 153-156, 1996 (Jpn, with Eng abstract)
14. Ohman J, Servo A, Heiskanen O: Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 197-201, 1991
15. Ranby M, Nguyen G, Scarabin PY, Samama M: Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assay. Thromb Haemost 30: 409-414, 1989
16. Suzuki M, Kudo A, Otawara Y, Hirashima Y, Takaku A, Ogawa A: Extrinsic pathway of blood coagulation and thrombin in the cerebrospinal fluid after subarachnoid hemorrhage. Neurosurgery 44: 487-494, 1999
17. Zabramski JM, Spetzler RF, Lee KS, Papadopoulos SM, Bovill E, Zimmerman RS, Bederson JB: Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 189-196, 1991